Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2Jennifer L Spratlin, Roger B Cohen, Matthew Eadens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinomaSteven J Cohen, Linus Ho, Sulabha Ranganathan, et al.
Patient Education and Counseling|May 13, 2014
Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) studyLinda Fleisher, Dominique G Ruggieri, Suzanne M Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximabShirin Khambata-Ford, Christopher R Garrett, Neal J Meropol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsNeal J Meropol, Yu-Ning Wong, Terrance Albrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Financial Concerns About Participation in Clinical Trials Among Patients With CancerYu-Ning Wong, Mark D Schluchter, Terrance L Albrecht, et al.
The Oncologist|December 15, 2025
Intergroup Randomized Phase III Study of Adjuvant FOLFIRI, FOLFOX, or 5-FU/Leucovorin for Stage II/III Rectal Cancer: ECOG-ACRIN E3201Audrey E Kam, Fengmin Zhao, Neal J Meropol, et al.
Clinical Colorectal Cancer|September 2, 2006
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancerSteven J Cohen, R Katherine Alpaugh, Steve Gross, et al.
Cancer Research|September 10, 2020
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against <i>PIK3CA</i>-Mutant Colorectal CancersYiqing Zhao, Xiujing Feng, Yicheng Chen, et al.
Cancer|January 22, 2013
A Web-based communication aid for patients with cancer: the CONNECT StudyNeal J Meropol, Brian L Egleston, Joanne S Buzaglo, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2Jennifer L Spratlin, Roger B Cohen, Matthew Eadens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinomaSteven J Cohen, Linus Ho, Sulabha Ranganathan, et al.
Patient Education and Counseling|May 13, 2014
Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) studyLinda Fleisher, Dominique G Ruggieri, Suzanne M Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximabShirin Khambata-Ford, Christopher R Garrett, Neal J Meropol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsNeal J Meropol, Yu-Ning Wong, Terrance Albrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Financial Concerns About Participation in Clinical Trials Among Patients With CancerYu-Ning Wong, Mark D Schluchter, Terrance L Albrecht, et al.
The Oncologist|December 15, 2025
Intergroup Randomized Phase III Study of Adjuvant FOLFIRI, FOLFOX, or 5-FU/Leucovorin for Stage II/III Rectal Cancer: ECOG-ACRIN E3201Audrey E Kam, Fengmin Zhao, Neal J Meropol, et al.
Clinical Colorectal Cancer|September 2, 2006
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancerSteven J Cohen, R Katherine Alpaugh, Steve Gross, et al.
Cancer Research|September 10, 2020
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against <i>PIK3CA</i>-Mutant Colorectal CancersYiqing Zhao, Xiujing Feng, Yicheng Chen, et al.
Cancer|January 22, 2013
A Web-based communication aid for patients with cancer: the CONNECT StudyNeal J Meropol, Brian L Egleston, Joanne S Buzaglo, et al.
Pageof 23